MicroRNAs in Esophageal Cancer: Implications for Diagnosis, Progression, Prognosis and Chemoresistance
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27020878 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Erica Cataldi-Stagetti und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40126 Bologna, Italy. Hauptthemen laut MEDLINE: Esophageal Neoplasms, MicroRNAs, Drug Resistance, Neoplasm, Biomarkers, Tumor. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 243 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cassa di Risparmio in Bologna, IRCCS - AOU Policlinico Sant'Orsola, IRCCS – AOU Policlinico Sant’Orsola.
Abstract (Originalsprache)
Esophageal cancer (EC), including esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC), remains a highly lethal disease because of its late diagnosis, significant biological heterogeneity, and frequent resistance to therapy. Growing evidence indicates that microRNAs (miRNAs) are key posttranscriptional regulators involved in tumor initiation, progression, metastasis, and response to treatment. This review provides a comprehensive and updated overview of miRNA dysregulation in both ESCC and EAC, with a specific focus on its emerging clinical relevance in early detection, prognostic assessment, and prediction of therapeutic response. Multiple tissue-based and circulating miRNA signatures, some capable of distinguishing between Barrett’s esophagus (BE), dysplasia, and EAC, demonstrate promising diagnostic performance. In parallel, several miRNAs, including miR-21, miR-23a, miR-455-3p, and miR-196b, have been consistently associated with chemoresistance and radioresistance. Moreover, distinct miRNA expression patterns are correlated with tumor aggressiveness, metastatic potential, and the risk of recurrence, supporting their integration with conventional histopathological and molecular parameters for improved patient stratification. Overall, miRNAs represent a powerful class of biomarkers and potential therapeutic targets in EC, with increasing translational relevance in precision oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40126 Bologna, Italy.
- SSD Medicina e Biologia Molecolare, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40126 Bologna, Italy.
- Gastro-Esophageal Organic Diseases Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
ORCID-Profile: Arianna Orsini, Rocco Maurizio Zagari
Förderung
- Cassa di Risparmio in Bologna
- IRCCS - AOU Policlinico Sant'Orsola
- IRCCS – AOU Policlinico Sant’Orsola
Zitieren
APA
Cataldi-Stagetti, E., Governatori, G., Orsini, A., De Nicolo, B., Zagari, R. M., & Bonora, E. (2026). MicroRNAs in Esophageal Cancer: Implications for Diagnosis, Progression, Prognosis and Chemoresistance. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27020878
Vancouver
Cataldi-Stagetti E, Governatori G, Orsini A, De Nicolo B, Zagari RM, Bonora E. MicroRNAs in Esophageal Cancer: Implications for Diagnosis, Progression, Prognosis and Chemoresistance. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27020878
BibTeX
@article{CataldiStagetti2026,
author = {Cataldi-Stagetti, Erica and Governatori, Giulia and Orsini, Arianna and De Nicolo, Bianca and Zagari, Rocco Maurizio and Bonora, Elena},
title = {MicroRNAs in Esophageal Cancer: Implications for Diagnosis, Progression, Prognosis and Chemoresistance},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27020878}
}
EUVIMED